Structure-function relationships of heparin species ( purification of highly active heparin / partial sequence of heparin / chemical composition of heparin )
R. Rosenberg,G. Armand,L. Lam
Abstract:We have fractionated porcine heparin species of low molecular weight, with an average specific anticoagulant activity of 96 units/mg by affinity chromotography. Highly active and relatively inactive preparations of similar size were obtained with specific anticoagulant activities of 360 and 4 units/mg, respectively. The highly active heparin fraction possesses 1.1 additional residues of glucuronic acid and 1.5 fewer residues of N-sulfated glucosamine per molecule compared to the relatively inactive species. This decrease in N-sulfated glucosamine appears to be secondary to a corresponding increase in N-acetylated glucosamine. This form also contains a tetrasaccharide sequence with a N-sulfated glucosamine at its reducing end as well as equivalent amounts of glucuronic acid and iduronic acid. Furthermore, the internal glucosamine residue of this sequence appears to be N-acetylated. Sufficient amounts of this tetrasaccharide sequence are present within the highly active preparation such that each molecule may be endowed with this structure. The relatively inactive product contains a significantly decreased quantity of this tetrasaccharide sequence such that only £-20% of these molecules may possess this structure. The mean distance between nonsulfated uronic acid residues of the highly active species is smaller than that separating similar residues of the relatively inactive product. In addition, a larger number of the nonsulfated uronic acid residues of the highly active material appears either to be present in a restricted region of the molecule separated only by glucosamine residues or to be located at penultimate positions within the polysaccharide chain. Heparin functions as an anticoagulant by binding to antithrombin and accelerating the rate at which this protein inactivates the serine proteases of the hemostatic mechanism (1). During the last 60 years, a number of investigators have attempted to define the chemical and physical features of heparin that are responsible for its anticoagulant action. However, the precise relationship between the structure of the mucopolysaccharide and its biologic properties has remained elusive. A communication from our laboratory provided evidence that only a small fraction (25-35%) of a given heparin preparation binds tightly to antithrombin and is responsible for 85-95% of the anticoagulant activity (2). This finding engendered the hope that, once the active fraction was carefully examined, a unique structure-function relationship for heparin would emerge. The existence of active and relatively inactive heparin species has been confirmed by Lindahl and his coworkers (3). Unfortunately, these investigators were unable to find any chemical parameters that distinguished between their two heparin fractions (3). MATERIALS AND METHODS Human antithrombin and human thrombin were both isolated by methods previously reported from our laboratory (4). Two porcine heparin products were utilized as starting material for The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "adverttsement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 3065 affinity fractionation. The first was a commercial preparation provided by Riker Laboratories (specific activity, 142 USP units/mg). The second was obtained at an early stage in the manufacturing process from the Wilson Chemical Co., Chicago, IL, and was extensively purified by cetylpyridinium chloride precipitation (CPC heparin) (5). To obtain low molecular weight forms of heparin, 4 g of either mucopolysaccharide was filtered at flow rates of 40 ml/hr through columns of Sephadex G-100 (5 X 190 cm) equilibrated with 0.15 M NaCI/0.01 M Tris-HCI, pH 7.5. The column effluents were monitored for mucopolysaccharide by the carbazole reaction and for anticoagulant activity as described below. Fractions of molecular weight 6000-8000 (average specific activity, 96.1 units/mg) were pooled. The mucopolysaccharide concentration of a given sample was determined by assay of uronic acid (6) or hexosamine (7). The anticoagulant activity of each fraction was established by quantitating its ability to accelerate the interaction of human antithrombin with human thrombin and comparing the extent of enzyme neutralization to that generated by a heparin standard of known USP potency. The molecular weights of heparin samples were determined by gel chromatography on a Sephadex G-100 column (0.6 X 190 cm) equilibrated with 0.5 M NaCl/0.01 M Tris-HCl, pH 7.5. The column was calibrated with heparin standards whose molecular weights had been established by analytic ultracentrifugation and viscometry (8). The total sulfate content of heparin fractions was measured as described by Dodgson and Price (9). Prior to analysis, samples were treated with Amberlite-400 (hydroxide form) to remove contaminating inorganic ions and hydrolyzed in 1 .M HCl for 8 hr at 1000. The N-sulfate content of mucopolysaccharides was estimated by comparing the amount of 2,5-anhydro-D-mannose formed after treatment with nitrous acid (10) to the total hexosamine present (7). The relative proportions of iduronic acid and glucuronic acid within a heparin fraction was established by the technique of Shively and Conrad (11, 12). The amount of galactosamine and glucosamine in various samples was estimated by hydrolyzing fractions in 6 M HCI for 8 hr at 1000, degrading the respective hexosamines to their corresponding pentoses with ninhydrin, separating the various components by paper chromatography utilizing butanol/ethanol/water, 4:1:1 (vol/vol), as solvent, and detecting the resolved species by staining with silver dip reagent. Nitrous acid degradation of heparin samples and aldehyde reduction of the resultant fragments with sodium boro[3H]hydride were carried out by the method of Shively and Conrad (11, 12). The various species were separated by paper chromatography with solvent system I [butanol/acetic acid/ ammonium hydroxide, 2:3:2.0 (vol/vol)] or solvent system II (butanol/acetic acid/ammonium hydroxide, 2:3:1.0.). Once isolated, these components were further analyzed by highAbbreviation: CPC heparin, crude heparin purified by cetylpyridinium chloride precipitation. 3066 Biochemistry: Rosenberg et al. voltage paper electrophoresis with a pyridine/formic acid/ water buffer, 1:10:4000, and a potential difference of 45 V/cm. Thereafter, uronic acid composition and the nature of the reducing end group were established for each species (11, 12). Heparin samples were also degraded at -20° for 16 hr with butyl nitrite and separated by Sephadex G-25 chromatography as described by Cifonelli and King (13, 14).